Phreesia, Inc. (NYSE:PHR) Receives $16.65 Average Target Price from Brokerages

Shares of Phreesia, Inc. (NYSE:PHR) have received a consensus rating of “Hold” from the nineteen brokerages that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and nine have given a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $16.6471.

Several research firms have issued reports on PHR. KeyCorp dropped their price objective on Phreesia from $15.00 to $12.00 and set an “overweight” rating on the stock in a report on Monday, April 13th. Stephens dropped their price objective on Phreesia from $32.00 to $20.00 and set an “overweight” rating on the stock in a report on Tuesday, March 31st. DA Davidson restated a “buy” rating and set a $14.00 price objective on shares of Phreesia in a report on Thursday, May 28th. Needham & Company LLC dropped their price objective on Phreesia from $35.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, March 31st. Finally, Robert W. Baird restated a “neutral” rating and set a $10.00 price objective (down from $25.00) on shares of Phreesia in a report on Tuesday, March 31st.

Phreesia Stock Performance

Phreesia stock opened at $9.55 on Friday. The stock’s 50 day moving average price is $9.30 and its 200 day moving average price is $13.13. The firm has a market capitalization of $590.16 million, a PE ratio of 63.65 and a beta of 0.91. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 1.76. Phreesia has a one year low of $7.77 and a one year high of $32.76.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Wednesday, May 27th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.02 by $0.03. The firm had revenue of $130.94 million for the quarter, compared to analyst estimates of $130.08 million. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.Phreesia’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the previous year, the company posted ($0.07) EPS. As a group, sell-side analysts expect that Phreesia will post 0.33 EPS for the current fiscal year.

More Phreesia News

Here are the key news stories impacting Phreesia this week:

• Negative Sentiment: Several law firms are advertising a securities fraud class action against Phreesia, increasing perceived legal and financial risk for shareholders.
• Negative Sentiment: The lead-plaintiff deadline on July 13, 2026 keeps the lawsuit in focus and may prolong overhang on the stock.
• Neutral Sentiment: One market commentary piece asked whether investors still believe in Phreesia’s upside potential, but it did not provide new company-specific operating news. Article Title

Insiders Place Their Bets

In other Phreesia news, General Counsel Allison C. Hoffman sold 6,176 shares of Phreesia stock in a transaction that occurred on Monday, April 20th. The stock was sold at an average price of $9.06, for a total transaction of $55,954.56. Following the sale, the general counsel directly owned 157,309 shares in the company, valued at $1,425,219.54. The trade was a 3.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Yvonne Hui sold 10,063 shares of Phreesia stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average price of $9.08, for a total value of $91,372.04. Following the sale, the insider owned 25,991 shares in the company, valued at $235,998.28. This represents a 27.91% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 50,493 shares of company stock valued at $461,983 over the last 90 days. 5.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. EverSource Wealth Advisors LLC grew its position in shares of Phreesia by 1,119.8% in the 1st quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after acquiring an additional 3,001 shares in the last quarter. Federated Hermes Inc. acquired a new position in shares of Phreesia in the 3rd quarter worth approximately $32,000. Van ECK Associates Corp grew its position in shares of Phreesia by 78.7% in the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after acquiring an additional 1,102 shares in the last quarter. New York State Teachers Retirement System acquired a new position in shares of Phreesia in the 1st quarter worth approximately $44,000. Finally, Rockefeller Capital Management L.P. grew its position in shares of Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after acquiring an additional 2,149 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.